1. Home
  2. JJSF vs MIRM Comparison

JJSF vs MIRM Comparison

Compare JJSF & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo J & J Snack Foods Corp.

JJSF

J & J Snack Foods Corp.

HOLD

Current Price

$92.51

Market Cap

1.8B

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$80.97

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JJSF
MIRM
Founded
1971
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
3.4B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
JJSF
MIRM
Price
$92.51
$80.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
11
Target Price
$138.33
$92.45
AVG Volume (30 Days)
293.3K
790.7K
Earning Date
02-02-2026
11-04-2025
Dividend Yield
3.46%
N/A
EPS Growth
N/A
N/A
EPS
3.36
N/A
Revenue
$3,166,466,000.00
$471,794,000.00
Revenue This Year
N/A
$53.78
Revenue Next Year
$2.24
$19.91
P/E Ratio
$27.51
N/A
Revenue Growth
0.54
53.66
52 Week Low
$80.67
$36.88
52 Week High
$165.39
$79.95

Technical Indicators

Market Signals
Indicator
JJSF
MIRM
Relative Strength Index (RSI) 51.53 71.50
Support Level $89.94 $63.23
Resistance Level $95.73 $66.77
Average True Range (ATR) 1.95 3.56
MACD 0.01 1.45
Stochastic Oscillator 39.95 99.92

Price Performance

Historical Comparison
JJSF
MIRM

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: